3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement Genetics Investing
DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting Pharmaceutical Investing
Algae Dynamics Corp Annouces C$400,000 Research Grant From Mitacs To Support Cannabis Research Pharmaceutical Investing
Phase 1 Clinical Trial Results Using Satipharm Capsules Published in International Medical Journal Cannabis Investing News
DelMar Pharmaceuticals Announces First Quarter Fiscal Year 2018 Financial Results Pharmaceutical Investing
